Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2022-08-16 Transaction in Own Shar…
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Zestawienie transakcji
Transaction in Own Shares Classification · 93% confidence The document text consists almost entirely of tabular data showing transaction records, including codes (KOD_PW), prices (KURS), values (WARTOSC), notification dates (DATA_NOTY), and settlement dates (DATA_ROZL). This structure strongly suggests a report detailing transactions, likely related to share movements or market activity. Given the options, this data format is most consistent with reports detailing insider transactions or significant share ownership changes. Since the data shows numerous small transactions over time rather than a single large event or a formal financial statement, it most closely aligns with Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). However, the data appears to be raw trade logs rather than a formal regulatory filing summarizing director trades or major holdings. In the context of the provided definitions, raw trade data like this, especially if it relates to insider activity, is often captured under Director's Dealing (DIRS). If it were a formal announcement of a change in major shareholding, it would be MRQ. Since the data is highly granular and transactional, and lacks typical regulatory headers (like 10-K, ER, etc.), and given the presence of 'PLBIOMX00015' which might indicate a specific exchange or security identifier, it is most likely a report of transactions. Without explicit context confirming these are directors, the closest fit among the transaction-focused codes is DIRS or MRQ. Given the high volume and continuous nature, it resembles a log of insider/director transactions. If this were a general regulatory announcement that didn't fit elsewhere, RNS would be the fallback. I will classify this as Director's Dealing (DIRS) as it represents transaction data, which is the core of DIRS, assuming the underlying context is insider trading reports, which often appear in this raw format in databases.
2022-08-16 English
Korekta raportu bieżącego nr 46 - Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 100% confidence The document explicitly details the acquisition of the company's own shares ('nabył akcji własnych') over several days (08.08.2022 to 12.08.2022) as part of a share repurchase program ('programu nabycia akcji własnych'). This activity directly corresponds to the definition of 'Transaction in Own Shares' (POS). The document is a correction/amendment to a previous report regarding these transactions, but the core subject remains the share repurchase activity.
2022-08-16 Polish
Zestawienie transakcji
Transaction in Own Shares Classification · 96% confidence The document text consists almost entirely of tabular data showing transaction records, including codes (KOD_PW), quantities (IL_ZREA), prices (KURS), total values (WARTOSC), notification dates (DATA_NOTY), and settlement dates (DATA_ROZL). This structure strongly suggests a report detailing transactions, likely related to share movements or market activity. Given the options, this data format is most consistent with insider trading reports (Director's Dealing - DIRS) or general market transaction reports. Since the data appears to be a raw log of transactions rather than a formal regulatory filing summary or a financial report, and it lacks specific context like '10-K' or 'Earnings Release', it most closely aligns with the type of data reported in Director's Dealing (DIRS) or potentially a general Regulatory Filing (RNS) if it's a foreign exchange filing. However, the presence of transaction details (price, quantity) points towards insider activity or share movement reporting. Without explicit context identifying the entity or the nature of the transaction (e.g., buy/sell by a director), the most appropriate classification for raw transaction logs that aren't standard financial statements is often the general regulatory category, RNS, or if we infer the context of insider reporting based on the structure, DIRS. Given the highly structured, repetitive nature of price/volume data, it resembles a transaction log. If this were a report of a director's dealing, it would fit DIRS. If it's a general market data dump, RNS is the fallback. Since the data is highly specific (transaction by transaction), and DIRS covers 'Report of personal share transactions by company directors and executives (insider trades)', this is a strong candidate if the underlying context is insider trading. If we treat this as a raw data dump that doesn't fit other specific financial reports (10-K, IR, ER), RNS is the safest fallback. Given the lack of narrative and the focus on price/volume changes over time, it is most likely a regulatory filing of transactions. I will classify it as RNS (Regulatory Filings) as the most general fit for raw, non-narrative regulatory data dumps that don't explicitly match DIRS criteria (which usually require a narrative summary of the director/insider).
2022-08-12 English
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 99% confidence The document text explicitly details the acquisition of the company's own shares ('nabył akcji własnych') over several trading days (08.08.2022 to 12.08.2022), including the number of shares, average price, and resulting percentage of share capital. This activity directly corresponds to a share repurchase program. The definition for 'Transaction in Own Shares' (Code: POS) covers the company buying back or selling its own shares (share repurchase/issuance). The document is a direct report of these transactions, not an announcement of a report, and its length is relatively short (2431 chars), but it contains the core data, making POS the most accurate classification over RPA or RNS.
2022-08-12 Polish
Zestawienie transakcji
Transaction in Own Shares Classification · 93% confidence The document text consists almost entirely of tabular data showing transaction records, including codes (KOD_PW), quantities (IL_ZREA), prices (KURS), values (WARTOSC), notification dates (DATA_NOTY), and settlement dates (DATA_ROZL). This structure strongly suggests a report detailing trading activity or market movements. Given the options, this data format is most characteristic of regulatory filings related to insider transactions or significant share ownership changes, or potentially a general regulatory announcement. Since the data appears to be raw transaction logs rather than a narrative report (like 10-K, ER, or IR), and it involves share movements, it aligns best with either Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). However, without explicit context identifying the reporting entity as a director or a major shareholder, and given the raw, time-stamped nature of the data which often accompanies general market disclosures in some jurisdictions, the most appropriate general category for raw, non-narrative regulatory data that doesn't fit a specific financial report type is Regulatory Filings (RNS). If this were confirmed to be insider trading data, DIRS would be better, but based purely on the structure of transaction logs, RNS serves as a strong fallback for market data disclosures. Revisiting the definitions: This is not an AGM, 10-K, AR, MANG, CT, CAP, DVA, DLST, ER, SR, XLSX, FS, CGR, IRAT, IR, IP, LTR, TAR, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. It could potentially be DIRS (Director's Dealing) or MRQ (Major Shareholding Notification) if the context was known, but since it's just raw transaction data without narrative context, RNS (General regulatory announcements/fallback) is the safest classification for unstructured market data dumps.
2022-08-05 English
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 99% confidence The document text, written in Polish, details the acquisition of the company's own shares ('akcji własnych') over several days (01.08.2022 to 05.08.2022) based on a resolution from the Annual General Meeting. It specifies the number of shares bought, the average price, and the resulting percentage of the share capital. This activity directly corresponds to the definition of a company buying back or selling its own shares. The relevant filing type is 'Transaction in Own Shares' (POS). The legal basis cited (Commission Delegated Regulation (EU) 2016/1052) also pertains to share repurchase programs.
2022-08-05 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.